ASSOCIATION OF GLUCOSE WITH GENERAL AND CARDIOVASCULAR MORTALITY AMONG POPULATION FROM 55 YEARS AND OLDER

Aim. To evaluate association of various blood glucose levels with overall and cardiovascular mortality (CVM) among population 55 y. o. and older.

Material and methods. Current paper represents partially the prospective study “Stress, ageing and health”. Totally, 1876 participants at the age 55 years and older included, assessed for traditional RF and presence of definite CHD according to quintile stratification by glucose levels in blood: <5,1 mmol/L, 5,1-5,5 mmol/L, 5,51-5,89 mmol/L, 5,9-6,59 mmol/L, >6,59 mmol/L. Epidemiological diagnosis of definite CHD was set based upon the algoritms and questionnaire by Rose and results of ECG by Minnessota coding. Follow-up lasted in average for 7,05 years. Totally, 411 lethal cases registered, among those 247 — from CVD. Statistics was done with STATA software.

Results. Relative total risk of death after correction by sex, age and diabetes was significantly higher among those with glucose lower than 5,1 mmol/L. Such relations of glucose and total mortality were significant after correction for sex, age, diabetes, CHD and/or traditional risk factors. Also, the most prominent decrease of morality is found in glucose level 5,51-5,89 mmol/L. However, the highest glucose levels are associated with higher mortality, but not significantly. When assessing impact of glucose on CVM, same associations were found, though not so much significant. Significant relation of CVM was found just for glucose level equal to 5,51-5,89 mmol/L.

Conclusion. Association of glucose with overall and CVM in population 55 y. o. and older is L-shaped. The highest overall and CVM is found in persons with glucose <5,1 mmol/L.

1. Dedov II, Shestakova MV, Vikulova OK. National register of diabetes mellitus in Russian Federation. The Diabetes Mellitus, 2015; 18(3): 5-22. Russian (Дедов ИИ, Шестакова МВ, Викулова ОК. Государственный регистр сахарного диабета в Российской Федерации: статус 2014 г. и перспективы развития. Сахарный диабет, 2015; 18(3): 5-22).

2. Shalnova SA, Smirnov DA, Deev AD, et al. Detection of diabetes mellitus in the older population of a large Russian city. Cardiovascular Therapy and Prevention, 2013; 4: 36-40. Russian (Шальнова С. А., Смирнов Д. А., Деев А. Д., и др. Выявление сахарного диабета в популяции пожилого населения крупного российского города. Кардиоваскулярная терапия и профилактика, 2013; 4: 36-40).

3. Bragg F, Li L, Smith M, Guo Y, et al. Associations of blood glucose and prevalent diabetes with risk of cardiovascular disease in 500 000 adult Chinese: the China Kadoorie Biobank. Diabet Med. 2014; 31(5): 540-51.

4. Chen Q, Zhang Y, Ding D, et al. Metabolic syndrome and its individual components with mortality among patients with coronary heart disease. Int J Cardiol 2016; 22; 224:8-14.

5. Braun J, Bopp M, Faeh D . B lood glucose may be an alternative to cholesterol in CVD risk prediction charts. Cardiovasc Diabetol 2013; 12:24.

6. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 2002; 105(3): 310–5.

7. D’Agostino RBSr, Grundy S, Sullivan LM, Wilson P. CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. Jama 2001; 286(2):180–7.

8. Mortimer JA, Borenstein AR, Ding D, et al. High normal fasting blood glucose is associated with dementia in Chinese elderly. Alzheimers Dement 2010; 6(6): 440-7.

9. Dahle CL, Jacobs BS, Raz N . Aging, Vascular Risk and Cognition: Blood Glucose, Pulse Pressure, and Cognitive Performance in Healthy Adults. Psychol Aging 2009; 24(1): 154-62.

10. Mannucci E, Monami M, Lamanna C, et al. Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials. Nutr Metab Cardiovasc Dis 2009; 19(9): 604-12.

11. Shkolnikova M, Shalnova S, Shkolnikov VM, et al. Biological mechanisms of disease and death in Moscow: rationale and design of the survey on Stress Aging and Health in Russia (SAHR). BMC Public Health 2009; 9: 293.

12. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular Survey Methods. World Health Organization. Geneva 1982; p. 123.

13. Abernathy JR, Thorn MD, Trobaugh GB, et al. Prevalence of ischemic resting and stress electrocardiographic abnormalities and angina among 40 — to 59-year-old men in selected U.S. and U.S.S.R. populations. Circulation 1988; 77 (2): 270-278.

14. Simons LA, Simons J, Friedlander Y, McCallum J. Usefulness of fasting plasma glucose to predict mortality or coronary heart disease in persons > or = 60 years of age without diabetes mellitus or in those with undiagnosed diabetes mellitus (from The Dubbo Study). Am J Cardiol 2008; 102(7): 831-4.

15. ORIGIN Trial Investigators. Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial. Eur Heart J. 2013; 34(40): 3137-44.

16. Razavi Nematollahi L, Kitabchi AE, Kitabchi AE, et al. Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects. Metabolism 2009; 58: 443–8.